Mitsubishi UFJ Morgan Stanley Securities’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
ETC
Mitsubishi UFJ Morgan Stanley Securities's BMY Position: Q2 2026 in Review
Mitsubishi UFJ Morgan Stanley Securities reduced its Bristol-Myers Squibb (BMY) stake by 64% in Q2 2026, selling an estimated $117K and leaving 1,123 shares worth $64.7K. The position accounts for 0.2% of the portfolio, ranked #110.
Mitsubishi UFJ Morgan Stanley Securities first reported a position in BMY in Q2 2013 and has held it in 9 quarters since. The position peaked at $218K in Q4 2025. 879 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Mitsubishi UFJ Morgan Stanley Securities held 1,123 shares of Bristol-Myers Squibb worth $64.7K as of Q2 2026.
- Mitsubishi UFJ Morgan Stanley Securities sold 2,032 Bristol-Myers Squibb shares in Q2 2026, an estimated $117K.
- Bristol-Myers Squibb made up 0.2% of Mitsubishi UFJ Morgan Stanley Securities's portfolio in Q2 2026, its #110 holding.
- Mitsubishi UFJ Morgan Stanley Securities first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 9 quarters since.
- Mitsubishi UFJ Morgan Stanley Securities's Bristol-Myers Squibb position peaked at $218K in Q4 2025.
- 879 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Mitsubishi UFJ Morgan Stanley Securities's 13F filing for Q2 2026, filed 15 Jul 2026.